Consistent with previous reports linking soluble plasma TNF-α receptor (sTNFR1) levels with cachexia (63), sTNFR1 levels in animals treated with anti–IFN-α were significantly reduced before and after ATI (Figure 3B). This evidence concerns the gene IFNA1 and Cachexia.